Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Philip Rosen

Colon & Rectal Surgery Tucson, AZ Medical Doctor

NPI 1437595642 CMS profile 11253819

1501 N Campbell Ave, Tucson, AZ 85724

Open in the dashboard

General payments

$16,791

54 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Philip Rosen of Tucson, AZ is reported in the CMS Open Payments database as having received $16,791 across 54 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,362 15
2024 General $2,539 14
2023 General $10,237 18
2022 General $1,541 6
2021 General $112 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Philip Rosen
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Philip Rosen were reported at $2,362. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Philip Rosen Colon & Rectal Surgery median Middle half National median
2019 $0 $443 $125–$2,179 $163
2020 $0 $167 $53–$931 $114
2021 $112 $207 $72–$1,272 $132
2022 $1,541 $341 $111–$1,587 $149
2023 $10,237 $322 $115–$1,420 $160
2024 $2,539 $328 $112–$1,354 $164
2025 $2,362 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Intuitive Surgical, Inc. $15,251 33 payments
  2. Medtronic, Inc. $975 15 payments
  3. Avita Medical Americas, LLC $148 1 payment
  4. Davol Inc. $134 1 payment
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $112 1 payment
  6. Atricure, Inc. $109 1 payment
  7. Ethicon US, LLC $62 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Education $11,082 6 payments
  2. Travel and Lodging $4,208 28 payments
  3. Food and Beverage $1,484 19 payments
  4. Gift $16 1 payment
Products named General payments · program years 2021–2025
  1. DAVINCI XI $11,000 5 payments
  2. Da Vinci Surgical System $4,251 28 payments
  3. INTERSTIM $783 12 payments
  4. Signia $192 3 payments
  5. Recell $148 1 payment
  6. Phasix Mesh $134 1 payment
  7. JARDIANCE $112 1 payment
  8. AtriCure cryoICE cryoSPHERE Cryoablation System $109 1 payment
  9. Echelon Flex $62 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

119

Median for Colorectal Surgery (Proctology): 106

Drug cost

$1,879

Median for Colorectal Surgery (Proctology): $1,614

Branded share of claims

48.7%

Median for Colorectal Surgery (Proctology): 35.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Loperamide Loperamide Hcl Brand 20 $814
Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 22 $315
Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 16 $251
Omeprazole Generic 13 $238
Cyclobenzaprine Hcl Generic 13 $144
Neomycin Sulfate Generic 18 $87
Metronidazole Generic 17 $30

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,507 Part D prescribers listed as Colorectal Surgery (Proctology); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$56,243

Medicare's payments for the services billed

Medicare patients

124

Average age 72

Services billed

348

64 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 48%
Ischemic heart disease 34%
Diabetes 31%
Chronic kidney disease 29%
Cancer 29%
Depression 28%
Heart failure 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

54 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record